Your browser doesn't support javascript.
loading
Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain.
Barrecheguren, Miriam; Monteagudo, Monica; Miravitlles, Marc; Flor, Xavier; Núñez, Alexa; Osorio, Jeisson; Muñoz, Xavier; Ojanguren, Iñigo.
Afiliación
  • Barrecheguren M; Department of Pneumology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. mbarrecheguren@vhebron.net.
  • Monteagudo M; Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain. mbarrecheguren@vhebron.net.
  • Miravitlles M; Institut Universitari d'Investigació en Atenció Primària (IDIAP) Jordi Gol, Barcelona, Spain.
  • Flor X; Department of Pneumology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Núñez A; Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Osorio J; Centre d'Atenció Primària (CAP) Chafarinas, Institut Català de la Salut (ICS), Barcelona, Spain.
  • Muñoz X; Department of Medicine, Universidad Autónoma de Barcelona, Barcelona, Spain.
  • Ojanguren I; Department of Pneumology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
NPJ Prim Care Respir Med ; 32(1): 11, 2022 03 10.
Article en En | MEDLINE | ID: mdl-35273167
ABSTRACT
The aim of this observational, retrospective study was to describe characteristics, treatment patterns, and adherence among patients with asthma who initiated multiple-inhaler triple therapy (MITT) in Catalonia, Spain. This study used data of patients initiating MITT in 2016 from the SIDIAP (Information System for Research in Primary Care) database, which covers ~80% of the Catalonian population (5.8 million). Of 1,204 patients initiating MITT, 361 (30.0%) stepped down (discontinued ≥ 1 and continued ≥1 MITT component) and 89 (7.4%) stopped all three components of MITT for a period of 60 days during the following 12 months. In the follow-up period, 196 (16.3%) patients were considered adherent to MITT (>0.8 proportion of days covered [PDC]), with a mean (standard deviation) PDC of 0.52 (0.51) days. Given the low adherence and substantial rates of step down/discontinuation among patients initiating MITT, there is an urgent need to implement strategies to improve treatment adherence/persistence.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Observational_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: NPJ Prim Care Respir Med Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Observational_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: NPJ Prim Care Respir Med Año: 2022 Tipo del documento: Article País de afiliación: España